WIRE — The Molbio Diagnostics public issue comprises a fresh issue of Rs 200 crore and an offer for sale of Rs 740 crore by existing shareholders.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.